H1B Report
Side-by-side comparison

Signature Healthcare Medical Group, Inc. vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Signature Healthcare Medical Group, Inc.
MARank #FEIN 04-3306782
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricSignature Healthcare Medical Group, Inc.WIPRO LIMITED
Total filings9172,392
Certified %93.41%91.61%
Denied %4.40%0.37%
Withdrawn %2.20%1.37%
Cert-withdrawn %0.00%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateMANJ

Outcomes — Signature Healthcare Medical Group, Inc.

DOL case-status mix.

Outcome breakdown: Certified 93.4%, Withdrawn 2.2%, Denied 4.4%
Outcome breakdown
OutcomeShare
Certified93.4%
Withdrawn2.2%
Denied4.4%
Certified93.4%
Withdrawn2.2%
Denied4.4%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Signature Healthcare Medical Group, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY20115
FY20123
FY201316
FY20145
FY201513
FY201612
FY20174
FY20189
FY201911
FY20200
FY20211
FY20220
FY20231
FY20245
FY20251
FY20261
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — Signature Healthcare Medical Group, Inc.

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.